Transgenic Expressing Active Human LH Receptor in the Gonads Exhibit a Decreased Fecundity: Towards a Platform to Identify New Orally Active Modulators of Gonadotropin Receptor Activity

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Oct 26

PMID 39458908

Authors

Amir Mahamid

David Ben-Menahem

Affiliations

Soon will be listed here.

Abstract

Background/objectives: The gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and their receptors are major regulators of reproduction in mammals and are absent in insects. We previously established transgenic lines expressing a constitutively active human LH receptor variant (LHR) and the wild-type receptor (LHR; inactive in the absence of an agonist). That study showed that ubiquitously expression of LHR-but not of LHR-resulted in pupal lethality, and targeted expression in midline cells resulted in thorax/bristles defects. To further study the model for an in vivo drug screening platform, we investigated here whether expressing LHR in the fly gonads alters reproduction, as shown in a transgenic mice model.

Methods: The receptor was expressed in somatic cells of the gonads using the tissue-specific -Gal4 driver. Western blot analysis confirmed receptor expression in the ovaries.

Results: A fecundity assay indicated that the ectopic expression of LHR resulted in a decrease in egg laying compared to control flies carrying, but not expressing the transgene (~40% decrease in two independent fly lines, < 0.001). No significant reduction in the number of laid eggs was seen in flies expressing the LHR (<10% decrease compared to non-driven flies, > 0.05). The decreased egg laying demonstrates a phenotype of the active receptor in the fly gonads, the prime target organs of the gonadotropins in mammals. We suggest that this versatile model can be used for the pharmacological search for gonadotropin modulators.

Conclusions: This is expected to provide: (a) new mimetic drug candidates (receptor-agonists/signaling-activators) for assisted reproduction treatment, (b) blockers for potential fertility regulation, and (c) leads relevant for the purpose of managing extra gonadotropic reported activities.

References

Hai L, McGee S, Rabideau A, Paquet M, Narayan P . Infertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries. Biol Reprod. 2015; 93(1):16. PMC: 4706306. DOI: 10.1095/biolreprod.115.129072. View

Fortini M, Skupski M, Boguski M, Hariharan I . A survey of human disease gene counterparts in the Drosophila genome. J Cell Biol. 2000; 150(2):F23-30. PMC: 2180233. DOI: 10.1083/jcb.150.2.f23. View

Adashi E, Hsueh A, Yen S . Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology. 1981; 108(4):1441-9. DOI: 10.1210/endo-108-4-1441. View

Leung P, Steele G . Intracellular signaling in the gonads. Endocr Rev. 1992; 13(3):476-98. DOI: 10.1210/edrv-13-3-476. View

Hsu S, Nakabayashi K, Bhalla A . Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5. Mol Endocrinol. 2002; 16(7):1538-51. DOI: 10.1210/mend.16.7.0871. View

Deady L, Shen W, Mosure S, Spradling A, Sun J . Matrix metalloproteinase 2 is required for ovulation and corpus luteum formation in Drosophila. PLoS Genet. 2015; 11(2):e1004989. PMC: 4335033. DOI: 10.1371/journal.pgen.1004989. View

Sudo S, Kuwabara Y, Park J, Hsu S, Hsueh A . Heterodimeric fly glycoprotein hormone-alpha2 (GPA2) and glycoprotein hormone-beta5 (GPB5) activate fly leucine-rich repeat-containing G protein-coupled receptor-1 (DLGR1) and stimulation of human thyrotropin receptors by chimeric fly GPA2 and human.... Endocrinology. 2005; 146(8):3596-604. DOI: 10.1210/en.2005-0317. View

Conti M, Hsieh M, Park J, Su Y . Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol. 2005; 20(4):715-23. DOI: 10.1210/me.2005-0185. View

Hauser F, Nothacker H, Grimmelikhuijzen C . Molecular cloning, genomic organization, and developmental regulation of a novel receptor from Drosophila melanogaster structurally related to members of the thyroid-stimulating hormone, follicle-stimulating hormone, luteinizing.... J Biol Chem. 1997; 272(2):1002-10. DOI: 10.1074/jbc.272.2.1002. View

10.

Crawford E, Schally A . The role of FSH and LH in prostate cancer and cardiometabolic comorbidities. Can J Urol. 2020; 27(2):10167-10173. View

11.

Tsafriri A . Ovulation as a tissue remodelling process. Proteolysis and cumulus expansion. Adv Exp Med Biol. 1995; 377:121-40. DOI: 10.1007/978-1-4899-0952-7_8. View

12.

Davies S, Bax C, Chatzaki E, Chard T, Iles R . Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br J Cancer. 2000; 83(12):1730-4. PMC: 2363464. DOI: 10.1054/bjoc.2000.1507. View

13.

Simoni M, Gromoll J, Nieschlag E . The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev. 1997; 18(6):739-73. DOI: 10.1210/edrv.18.6.0320. View

14.

Kuczer M, Rosinski G, Konopinska D . Insect gonadotropic peptide hormones: some recent developments. J Pept Sci. 2006; 13(1):16-26. DOI: 10.1002/psc.792. View

15.

Liu G, Duranteau L, Carel J, Monroe J, Doyle D, Shenker A . Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med. 1999; 341(23):1731-6. DOI: 10.1056/NEJM199912023412304. View

16.

Sangkuhl K, Schulz A, Schultz G, Schoneberg T . Structural requirements for mutational lutropin/choriogonadotropin receptor activation. J Biol Chem. 2002; 277(49):47748-55. DOI: 10.1074/jbc.M203491200. View

17.

Moulton M, Letsou A . Modeling congenital disease and inborn errors of development in Drosophila melanogaster. Dis Model Mech. 2016; 9(3):253-69. PMC: 4826979. DOI: 10.1242/dmm.023564. View

18.

Belchetz P, Plant T, Nakai Y, Keogh E, Knobil E . Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science. 1978; 202(4368):631-3. DOI: 10.1126/science.100883. View

19.

Casarini L, Santi D, Brigante G, Simoni M . Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG. Endocr Rev. 2018; 39(5):549-592. DOI: 10.1210/er.2018-00065. View

20.

Webber K, Perry G, Smith M, Casadesus G . The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Clin Med Res. 2007; 5(3):177-83. PMC: 2111407. DOI: 10.3121/cmr.2007.741. View